NEW YORK (GenomeWeb News) – Rosetta Genomics has named Ron Kalfus to be chief financial officer, starting this week. Kalfus previously was CFO and treasurer at MabCure, a biotech startup focused on antibody-based cancer detection, and before that he handled financial reporting to the SEC for Toys "R" Us.
Rubicon Genomics has hired Kenneth Solomon as director of sales and marketing. He has previously held positions at Centocor Ortho Biotech, Pharmacia/Searle, Biomet, and Boehringer Mannheim.
Quidel's seven-member board of directors has been re-elected by shareholders. The board members include Thomas Brown; President and CEO Douglas Bryant; Kenneth Buechler; Rod Dammeyer; Mary Lake Polan; Mark Pulido; and Jack Schuler.
Applied Nanotech Holdings has hired Alan Jernigan to be CEO of a new subsidiary that will focus on sensor commercialization. Jernigan formerly was COO of One Lambda, and he worked in diagnostics development and commercialization at Abbott, Idexx, Igen, and Thrombovision.
Becton Dickinson said this week that Chairman of the Board Edward Ludwig will retire from the company, and CEO and President Vincent Forlenza will take over Ludwig's chairman position. Forlenza, who has been at BD since 1980, was named president in 2009 and CEO in late 2011.
EMD Millipore, the life science division of Merck KGaA of Darmstadt, Germany, announced that John Sweeney, head of the life science business field at EMD Millipore has been appointed head of the company’s bioscience business unit. Sweeney, who has been with Millipore since 2003, succeeds Jon DiVincenzo.
Gen-Probe shareholders have re-elected John Brown and John Martin to serve three-year terms on its board of directors. Brown has been a director at company since 2005, and Martin has been on the board since 2007.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.